Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033392183> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W3033392183 endingPage "1507" @default.
- W3033392183 startingPage "1506.1" @default.
- W3033392183 abstract "Background: The traditional lupus nephritis (LN) biomarkers are not sensitive nor specific enough for detecting ongoing disease activity and early relapse of nephritis and they do not reflect kidney damage nor have prognostic value 1 . Urinary biomarkers are directly excreted by the kidney and are easily obtained. They can also differentiate the renal activity of the disease from other organic manifestations more accurately than the serum biomarkers 2 . Vascular cell adhesion molecule-1 (VCAM-1) is involved in the progression of glomerular and tubulointerstitial injury in LN and its soluble form can be easily assessed in urine (uVCAM-1) 3 . Several studies correlated the uVCAM-1 levels with urine protein-creatinine ratio (UPC), with general disease activity and with active LN 3 . Objectives: To assess uVCAM-1 as a biomarker of disease activity and treatment response in LN. Methods: This prospective study enrolled patients with class III, IV or V LN diagnosed within the last three years and divided them in two groups: with and without active nephritis at the inclusion. The patients with active nephritis were included before they started a new immunosuppressive treatment. Active LN was defined as proteinuria (UPC≥0.5) plus active urinary sediment (hematuria, leukocyturia or cellular hematic/granular casts). At each visit, a urine sample was collected for uVCAM-1 evaluation and the nephritis status was accessed. Results: Median uVCAM-1 level was elevated in patients with active compared to inactive LN (p<0.001). The ROC curve of uVCAM-1 demonstrated an AUC of 0.84 and a cutoff of 47.2 ng/mgCr yielded a good sensitivity (74.2%) and specificity (74.2%) for the diagnosis of active LN. A significant correlation was found between uVCAM-1 level and renal activity scores and traditional biomarkers of LN (table 1). The level of uVCAM-1 dropped in patients with active LN who went into remission (p<0.001), increased in patients who went into activity (p=0.002) and did not change in patients who remained inactive (p=0.797) (figure 1). The level of uVCAM-1 peaked during the flare of LN (p<0.05) (figure 2). Table 1. Correlations between urinary soluble VCAM-1 and other LN biomarkers/disease scores LN biomarkers/disease scores VCAM-1 SLEDAI-2k 0.597*** Renal SLEDAI 0.569*** Renal SLAM-R 0.470*** Renal SLICC 0.620*** Anti-dsDNA 0.342** C3 -0.344** C4 -0.382** UPC 0.654*** Spearman’s correlation coefficients * p value <0.05; ** p value <0.01; *** p value <0.001 C, complement; LN, lupus nephritis; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; renal SLAM-R, The renal Systemic Lupus Activity Measure revised; renal SLICC, The Systemic Lupus International Collaborating Clinics renal activity/response exercise; UPC, urine protein-creatinine ratio. Conclusion: The uVCAM-1 is a reliable biomarker that reflects renal disease activity and is useful for monitoring individual patients with lupus nephritis over time. References: [1] Mok CC. Biomarkers for lupus nephritis: A critical appraisal. J Biomed Biotechnol. 2010;2010:638413. [2] Reyes-Thomas J, Blanco I, Putterman C. Urinary Biomarkers in Lupus Nephritis. Clin Rev Allergy Immunol. 2010;40:138–50. [3] Gasparin AA, Pamplona Bueno de Andrade N, Hax V, Tres GL, Veronese FV, Monticielo OA. Urinary biomarkers for lupus nephritis: the role of the vascular cell adhesion molecule-1. Lupus. 2019;28:265-272. Acknowledgments: We acknowledge the Research Incentive Fund (FIPE/HCPA) and the Research Support Fund of Brazilian Society of Rheumatology that supported this work. Disclosure of Interests: Andrese Aline Gasparin: None declared, Nicole Pamplona Bueno de Andrade: None declared, Vanessa Hax: None declared, Penelope Palominos Grant/research support from: This work was sponsored by the regional society of rheumatology (Sociedade de Reumatologia do Rio Grande do Sul)., Marina Siebert: None declared, Romulo Marx: None declared, Pedro Shaefer: None declared, Francisco Veríssimo Veronese: None declared, Odirlei Monticielo: None declared" @default.
- W3033392183 created "2020-06-12" @default.
- W3033392183 creator A5005436584 @default.
- W3033392183 creator A5006513518 @default.
- W3033392183 creator A5014950444 @default.
- W3033392183 creator A5020895863 @default.
- W3033392183 creator A5024306540 @default.
- W3033392183 creator A5052386622 @default.
- W3033392183 creator A5062904791 @default.
- W3033392183 creator A5066169627 @default.
- W3033392183 creator A5078750653 @default.
- W3033392183 date "2020-06-01" @default.
- W3033392183 modified "2023-09-27" @default.
- W3033392183 title "AB0412 URINARY SOLUBLE VCAM-1 IS A USEFUL BIOMARKER OF DISEASE ACTIVITY AND TREATMENT RESPONSE IN LUPUS NEPHRITIS" @default.
- W3033392183 doi "https://doi.org/10.1136/annrheumdis-2020-eular.199" @default.
- W3033392183 hasPublicationYear "2020" @default.
- W3033392183 type Work @default.
- W3033392183 sameAs 3033392183 @default.
- W3033392183 citedByCount "3" @default.
- W3033392183 countsByYear W30333921832021 @default.
- W3033392183 countsByYear W30333921832022 @default.
- W3033392183 crossrefType "journal-article" @default.
- W3033392183 hasAuthorship W3033392183A5005436584 @default.
- W3033392183 hasAuthorship W3033392183A5006513518 @default.
- W3033392183 hasAuthorship W3033392183A5014950444 @default.
- W3033392183 hasAuthorship W3033392183A5020895863 @default.
- W3033392183 hasAuthorship W3033392183A5024306540 @default.
- W3033392183 hasAuthorship W3033392183A5052386622 @default.
- W3033392183 hasAuthorship W3033392183A5062904791 @default.
- W3033392183 hasAuthorship W3033392183A5066169627 @default.
- W3033392183 hasAuthorship W3033392183A5078750653 @default.
- W3033392183 hasBestOaLocation W30333921831 @default.
- W3033392183 hasConcept C126322002 @default.
- W3033392183 hasConcept C126894567 @default.
- W3033392183 hasConcept C142724271 @default.
- W3033392183 hasConcept C185592680 @default.
- W3033392183 hasConcept C188816634 @default.
- W3033392183 hasConcept C203014093 @default.
- W3033392183 hasConcept C2777058396 @default.
- W3033392183 hasConcept C2778653478 @default.
- W3033392183 hasConcept C2779134260 @default.
- W3033392183 hasConcept C2779225474 @default.
- W3033392183 hasConcept C2779561371 @default.
- W3033392183 hasConcept C2779912601 @default.
- W3033392183 hasConcept C2780026642 @default.
- W3033392183 hasConcept C2780091579 @default.
- W3033392183 hasConcept C2780306776 @default.
- W3033392183 hasConcept C2781197716 @default.
- W3033392183 hasConcept C55493867 @default.
- W3033392183 hasConcept C71924100 @default.
- W3033392183 hasConcept C77411442 @default.
- W3033392183 hasConcept C90924648 @default.
- W3033392183 hasConceptScore W3033392183C126322002 @default.
- W3033392183 hasConceptScore W3033392183C126894567 @default.
- W3033392183 hasConceptScore W3033392183C142724271 @default.
- W3033392183 hasConceptScore W3033392183C185592680 @default.
- W3033392183 hasConceptScore W3033392183C188816634 @default.
- W3033392183 hasConceptScore W3033392183C203014093 @default.
- W3033392183 hasConceptScore W3033392183C2777058396 @default.
- W3033392183 hasConceptScore W3033392183C2778653478 @default.
- W3033392183 hasConceptScore W3033392183C2779134260 @default.
- W3033392183 hasConceptScore W3033392183C2779225474 @default.
- W3033392183 hasConceptScore W3033392183C2779561371 @default.
- W3033392183 hasConceptScore W3033392183C2779912601 @default.
- W3033392183 hasConceptScore W3033392183C2780026642 @default.
- W3033392183 hasConceptScore W3033392183C2780091579 @default.
- W3033392183 hasConceptScore W3033392183C2780306776 @default.
- W3033392183 hasConceptScore W3033392183C2781197716 @default.
- W3033392183 hasConceptScore W3033392183C55493867 @default.
- W3033392183 hasConceptScore W3033392183C71924100 @default.
- W3033392183 hasConceptScore W3033392183C77411442 @default.
- W3033392183 hasConceptScore W3033392183C90924648 @default.
- W3033392183 hasIssue "Suppl 1" @default.
- W3033392183 hasLocation W30333921831 @default.
- W3033392183 hasOpenAccess W3033392183 @default.
- W3033392183 hasPrimaryLocation W30333921831 @default.
- W3033392183 hasRelatedWork W1776623507 @default.
- W3033392183 hasRelatedWork W1987376021 @default.
- W3033392183 hasRelatedWork W2082140799 @default.
- W3033392183 hasRelatedWork W2117625910 @default.
- W3033392183 hasRelatedWork W2294754443 @default.
- W3033392183 hasRelatedWork W2350791026 @default.
- W3033392183 hasRelatedWork W3006219398 @default.
- W3033392183 hasRelatedWork W3033392183 @default.
- W3033392183 hasRelatedWork W3148712325 @default.
- W3033392183 hasRelatedWork W2088864129 @default.
- W3033392183 hasVolume "79" @default.
- W3033392183 isParatext "false" @default.
- W3033392183 isRetracted "false" @default.
- W3033392183 magId "3033392183" @default.
- W3033392183 workType "article" @default.